Related references
Note: Only part of the references are listed.New strategies for inhibition of non-adrenergic prostate smooth muscle contraction by pharmacologic intervention
Qingfeng Yu et al.
PROSTATE (2019)
KV7 Channel Pharmacological Activation by the Novel Activator ML213: Role for Heteromeric KV7.4/KV7.5 Channels in Guinea Pig Detrusor Smooth Muscle Functions
Aaron Provence et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Naringenin inhibits prostate cancer metastasis by blocking voltage-gated sodium channels
Hatice Gumushan Aktas et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Angiotensin II Promotes K(v)7.4 Channels Degradation Through Reduced Interaction With HSP90 (Heat Shock Protein 90)
Vincenzo Barrese et al.
HYPERTENSION (2018)
Identification and validation of midbrain Kcnq4 regulation of heavy alcohol consumption in rodents
Natalie S. McGuier et al.
NEUROPHARMACOLOGY (2018)
Whole-exome sequencing identifies two novel mutations in KCNQ4 in individuals with nonsyndromic hearing loss
Jinsei Jung et al.
SCIENTIFIC REPORTS (2018)
KCNQ-Encoded Potassium Channels as Therapeutic Targets
Vincenzo Barrese et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 58 (2018)
KV7 channels in the human detrusor: channel modulator effects and gene and protein expression
Riccardo Bientinesi et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2017)
Targeting Kv7 channels in pain pathways
Ivan Rivera-Arconada et al.
ONCOTARGET (2017)
The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A systematic review and meta-analysis
Shaun Wen Huey Lee et al.
SCIENTIFIC REPORTS (2017)
The Kv7 Channel and Cardiovascular Risk Factors
Andreas L. Fosmo et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2017)
Kcne4 Deletion Sex-Dependently Alters Vascular Reactivity
Geoffrey W. Abbott et al.
JOURNAL OF VASCULAR RESEARCH (2016)
Effects of novel subtype selective M-current activators on spinal reflexes in vitro: Comparison with retigabine
Jorge Vicente-Baz et al.
NEUROPHARMACOLOGY (2016)
Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK
Mark Speakman et al.
BJU INTERNATIONAL (2015)
Functional and Molecular Evidence for Kv7 Channel Subtypes in Human Detrusor from Patients with and without Bladder Outflow Obstruction
Julie Svalo et al.
PLOS ONE (2015)
Vasorelaxant effects of novel Kv7.4 channel enhancers ML213 and NS15370
T. A. Jepps et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Effects of Schisandra chinensis extract on the relaxation of isolated human prostate tissue and smooth muscle cell
Seoi Ho Choo et al.
JOURNAL OF ETHNOPHARMACOLOGY (2014)
Prostatic α1-Adrenoceptors: New Concepts of Function, Regulation, and Intracellular Signaling
Martin Hennenberg et al.
NEUROUROLOGY AND URODYNAMICS (2014)
Differential Activation of Vascular Smooth Muscle Kv7.4, Kv7.5, and Kv7.4/7.5 Channels by ML213 and ICA-069673
Lyubov I. Brueggemann et al.
MOLECULAR PHARMACOLOGY (2014)
Discovery, Synthesis, and Structure-Activity Relationship of a Series of N-Aryl-bicyclo[2.2.1]heptane-2-carboxamides: Characterization of ML213 as a Novel KCNQ2 and KCNQ4 Potassium Channel Opener
Haibo Yu et al.
ACS CHEMICAL NEUROSCIENCE (2011)
Calcium Signaling in Smooth Muscle
David C. Hill-Eubanks et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
KCNQ potassium channels: physiology, pathophysiology, and pharmacology
J Robbins
PHARMACOLOGY & THERAPEUTICS (2001)